TrialPloS one2019

Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.

Sivasankaran Munusamy Ponnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.